Bamikeh Afrik

Bamikeh Afrik has worked in various roles within the pharmaceutical and regulatory affairs industry. They started their career as a Regulatory Affairs Fellow at the FDA, where they gained experience in filing review for generic drug applications. From there, they held positions at companies such as Pharmalink Consulting, DSFederal, AnGes Inc., and Amicus Therapeutics, where they worked in regulatory affairs and provided operational supervision for regulatory submission dossiers. They then joined Shire as a Global Regulatory CMC Submission Manager and later worked for Takeda as a Sr. Global Regulatory Portfolio Manager, responsible for managing regulatory goals for a portfolio of compounds. Afrik also worked at Adicet Bio, Inc as an Associate Program Director, translating corporate goals into program goals and managing timelines for cross-functional activities. Most recently, they worked at Nurix Therapeutics as a Director of Program & Portfolio Management, providing project management expertise for oncology early development assets. Overall, Afrik has a strong background in regulatory affairs and program management within the pharmaceutical industry.

Bamikeh Afrik obtained a Master's degree in Bioscience Regulatory Affairs from The Johns Hopkins University from 2013 to 2015. In 2014, they also completed a project management degree from PMI. They pursued a Graduate Certificate in Clinical Research Management from Walden University between 2011 and 2013. Bamikeh Afrik earned a Bachelor of Science degree in Biomedical Science and Psychology, Behavioral Research from Western Michigan University between 2004 and 2009. They also hold additional certifications, including RAC from Regulatory Affairs Professionals Society (RAPS) in 2014, DMAIC Project Methodology from SIX SIGMA, QUALITY TRAINING PORTAL in 2012, and Emergency Medical Technician certification from the National Registry for Emergency Medical Technician in 2009. Additionally, they obtained certifications in Basic Life Support (BLS), Advanded Cardiac Life Support (ACLS), and Pediatric Advance Life Support (PALS) from NATIONAL HEALTH CARE PROVIDER SOLUTIONS in 2009.